Cargando…
Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost‐effectiveness analysis of the STOP GAP trial
BACKGROUND: Pyoderma gangrenosum (PG) is a painful, ulcerating skin disease with poor evidence for management. Prednisolone and ciclosporin are the most commonly used treatments, although not previously compared within a randomized controlled trial (RCT). OBJECTIVES: To compare the cost‐effectivenes...
Autores principales: | Mason, J.M., Thomas, K.S., Ormerod, A.D., Craig, F.E., Mitchell, E., Norrie, J., Williams, H.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811816/ https://www.ncbi.nlm.nih.gov/pubmed/28391619 http://dx.doi.org/10.1111/bjd.15561 |
Ejemplares similares
-
UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial
por: Craig, Fiona F, et al.
Publicado: (2012) -
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
por: Ormerod, Anthony D, et al.
Publicado: (2015) -
Comparison of the two most commonly used treatments for pyoderma
gangrenosum: results of the STOP GAP randomised controlled trial
Publicado: (2017) -
Penile pyoderma gangrenosum
por: Philip, Mariam, et al.
Publicado: (2013) -
Pyoderma gangrenosum: An update
por: Bhat, Ramesh M.
Publicado: (2012)